Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Benatar

Showing results (151-160 of 242) with videos related to

Pageof 25
Sort By:
Neurology. Genetics|January 20, 2022
Revealing the Mutational Spectrum in Southern Africans With Amyotrophic Lateral SclerosisMelissa Nel, Amokelani C Mahungu, Nomakhosazana Monnakgotla, et al.
The Lancet. Neurology|October 26, 2017
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre studyJames F Howard, Kimiaki Utsugisawa, Michael Benatar, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 16, 2023
The amyotrophic lateral sclerosis-health index (ALS-HI): development and evaluation of a novel outcome measureAnika Varma, Jennifer Weinstein, Jamison Seabury, et al.
Brain : a Journal of Neurology|June 27, 2025
Extreme exercise in males is linked to mTOR signalling and onset of amyotrophic lateral sclerosisDavid O'Brien, Elham Alhathli, Ceryl Harwood, et al.
Eclinicalmedicine|December 19, 2022
Patient reported impact of symptoms in amyotrophic lateral sclerosis (PRISM-ALS): A national, cross-sectional studyChristine Zizzi, Jamison Seabury, Spencer Rosero, et al.
Frontiers in Neurology|September 15, 2023
The mutational profile in a South African cohort with inherited neuropathies and spastic paraplegiaAmokelani C Mahungu, Elizabeth Steyn, Niki Floudiotis, et al.
Muscle & Nerve|January 31, 2022
Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre-specified and post hoc analysesRobert G Miller, Rongzhen Zhang, Paige M Bracci, et al.
Neurology|July 31, 2023
Amyotrophic Lateral Sclerosis Quality Measurement Set 2022 Update: Quality Improvement in NeurologyKathryn A Kvam, Michael Benatar, Alisa Brownlee, et al.
Muscle & Nerve|November 26, 2013
Electrical impedance myography correlates with standard measures of ALS severitySeward B Rutkove, James B Caress, Michael S Cartwright, et al.
Journal of Neurology|January 28, 2024
Mismatch between clinically defined classification of ALS stage and the burden of cerebral pathologyPedram Parnianpour, Michael Benatar, Hannah Briemberg, et al.
Pageof 25

Showing results (151-160 of 242) with videos related to

Sort By:
Pageof 25
Neurology. Genetics|January 20, 2022
Revealing the Mutational Spectrum in Southern Africans With Amyotrophic Lateral SclerosisMelissa Nel, Amokelani C Mahungu, Nomakhosazana Monnakgotla, et al.
The Lancet. Neurology|October 26, 2017
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre studyJames F Howard, Kimiaki Utsugisawa, Michael Benatar, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 16, 2023
The amyotrophic lateral sclerosis-health index (ALS-HI): development and evaluation of a novel outcome measureAnika Varma, Jennifer Weinstein, Jamison Seabury, et al.
Brain : a Journal of Neurology|June 27, 2025
Extreme exercise in males is linked to mTOR signalling and onset of amyotrophic lateral sclerosisDavid O'Brien, Elham Alhathli, Ceryl Harwood, et al.
Eclinicalmedicine|December 19, 2022
Patient reported impact of symptoms in amyotrophic lateral sclerosis (PRISM-ALS): A national, cross-sectional studyChristine Zizzi, Jamison Seabury, Spencer Rosero, et al.
Frontiers in Neurology|September 15, 2023
The mutational profile in a South African cohort with inherited neuropathies and spastic paraplegiaAmokelani C Mahungu, Elizabeth Steyn, Niki Floudiotis, et al.
Muscle & Nerve|January 31, 2022
Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre-specified and post hoc analysesRobert G Miller, Rongzhen Zhang, Paige M Bracci, et al.
Neurology|July 31, 2023
Amyotrophic Lateral Sclerosis Quality Measurement Set 2022 Update: Quality Improvement in NeurologyKathryn A Kvam, Michael Benatar, Alisa Brownlee, et al.
Muscle & Nerve|November 26, 2013
Electrical impedance myography correlates with standard measures of ALS severitySeward B Rutkove, James B Caress, Michael S Cartwright, et al.
Journal of Neurology|January 28, 2024
Mismatch between clinically defined classification of ALS stage and the burden of cerebral pathologyPedram Parnianpour, Michael Benatar, Hannah Briemberg, et al.
Pageof 25